Literature DB >> 19121689

Development of aptamers specific for potential diagnostic targets in Burkholderia pseudomallei.

Annie J Gnanam1, Bradley Hall, Xiaofan Shen, Shawn Piasecki, Anna Vernados, Edouard E Galyov, Sophie J Smither, G Barrie Kitto, Richard W Titball, Andrew D Ellington, Katherine A Brown.   

Abstract

Improved diagnostic reagents would be of considerable benefit in enhancing the specificity and sensitivity of rapid assays for Burkholderia pseudomallei, the causative agent of melioidosis. The purpose of this work is to develop aptamers, high affinity RNA-based molecular recognition molecules, which could be used as reagents for identification of the whole organism in assays of biological samples. Data are presented demonstrating the purification of recombinant B. pseudomallei secreted or surface-exposed macromolecules, which have been expressed in Escherichia coli, and the initial stages of aptamer generation using these recombinant proteins. Future studies will focus upon the expansion of this methodology to include other target macromolecules located on or near the outer membrane of this organism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19121689      PMCID: PMC3636715          DOI: 10.1016/S0035-9203(08)70015-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  4 in total

1.  In vitro selection of RNA molecules that inhibit the activity of ricin A-chain.

Authors:  J R Hesselberth; D Miller; J Robertus; A D Ellington
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

Review 2.  Melioidosis.

Authors:  Sharon J Peacock
Journal:  Curr Opin Infect Dis       Date:  2006-10       Impact factor: 4.915

3.  Biophysical characterization of the catalytic domain of guanine nucleotide exchange factor BopE from Burkholderia pseudomallei.

Authors:  Abhishek Upadhyay; Christopher Williams; Andrew C Gill; Didier L Philippe; Kenneth Davis; Lowrie A Taylor; Mark P Stevens; Edouard E Galyov; Stefan Bagby
Journal:  Biochim Biophys Acta       Date:  2004-04-08

4.  Expression, purification, crystallization and preliminary crystallographic analysis of BipD, a component of the Burkholderia pseudomallei type III secretion system.

Authors:  Pietro Roversi; Steven Johnson; Terry Field; Janet E Deane; Edouard E Galyov; Susan M Lea
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-11
  4 in total
  5 in total

1.  Development of reagents and assays for the detection of pathogenic Burkholderia species.

Authors:  Omar Qazi; Mridula Rani; Annie J Gnanam; Thomas W Cullen; Christopher M Stead; Haley Kensing; Kate McCaul; Sarah Ngugi; Joann L Prior; Alexandria Lipka; Judit M Nagy; C Whitlock Gregory; Barbara M Judy; Sarah V Harding; Richard W Titball; Sachdev S Sidhu; M Stephen Trent; G Barrie Kitto; Alfredo Torres; D Mark Estes; Brent Iverson; George Georgiou; Katherine A Brown
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

2.  Application of aptamers in diagnostics, drug-delivery and imaging.

Authors:  Chetan Chandola; Sheetal Kalme; Marco G Casteleijn; Arto Urtti; Muniasamy Neerathilingam
Journal:  J Biosci       Date:  2016-09       Impact factor: 2.795

3.  Acyclic identification of aptamers for human alpha-thrombin using over-represented libraries and deep sequencing.

Authors:  Gillian V Kupakuwana; James E Crill; Mark P McPike; Philip N Borer
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240

Review 4.  Selection and analytical applications of aptamers binding microbial pathogens.

Authors:  Camille L A Hamula; Hongquan Zhang; Feng Li; Zhixin Wang; X Chris Le; Xing-Fang Li
Journal:  Trends Analyt Chem       Date:  2011-09-09       Impact factor: 12.296

Review 5.  BipD of Burkholderia pseudomallei: Structure, Functions, and Detection Methods.

Authors:  Kasturi Selvam; Muhammad Fazli Khalid; Khairul Mohd Fadzli Mustaffa; Azian Harun; Ismail Aziah
Journal:  Microorganisms       Date:  2021-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.